Clinical Trial Update: Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate ropivacaine-Poloxamer 407 gel for pain control after open gastrectomy in gastric cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Ropivacaine-Poloxamer 407 Gel (ropivacaine-poloxamer 407 gel)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Gastric Cancer | NA | Status: RECRUITING